OMNIABIO GLOBAL SHOWCASE PRESENTATION Meet OmniaBio: CCRM’s CDMO focused on CGT manufacturing
Wednesday, May 31, 2023 06:45 PM - 07:00 PM
Global Showcase Theater
Global Showcase Presentation
Meet OmniaBio: CCRM’s CDMO focused on CGT manufacturing
Presenter
Mitchel Sivilotti, CEO, OmniaBio Inc., Canada
OmniaBio’s expertise in iPSCs, Immunotherapy, and LVV represent some of the most promising routes to a disease-free future. As a CDMO focused on providing specialized services for cell and gene therapy (CGT) developers around the world, it’s no coincidence that OmniaBio excels and has demonstrable leadership in these three technology platforms.
As a CCRM subsidiary, OmniaBio builds on an established foundation and reputation in manufacturing for CGTs. Its capabilities leverage a team and legacy built over a decade. OmniaBio has extensive expertise in process and analytical development services, along with GMP-compliant manufacturing for CGT developers from pre-clinical to commercial stage. Once its second site is built (2026) OmniaBio will have 55 clean room suites across more than 400,000 square feet.
Presenter
Mitchel Sivilotti, CEO, OmniaBio Inc., Canada
OmniaBio’s expertise in iPSCs, Immunotherapy, and LVV represent some of the most promising routes to a disease-free future. As a CDMO focused on providing specialized services for cell and gene therapy (CGT) developers around the world, it’s no coincidence that OmniaBio excels and has demonstrable leadership in these three technology platforms.
As a CCRM subsidiary, OmniaBio builds on an established foundation and reputation in manufacturing for CGTs. Its capabilities leverage a team and legacy built over a decade. OmniaBio has extensive expertise in process and analytical development services, along with GMP-compliant manufacturing for CGT developers from pre-clinical to commercial stage. Once its second site is built (2026) OmniaBio will have 55 clean room suites across more than 400,000 square feet.
SPONSORED BY:
